Expert accunulation going on. Also longest tight trading range lasting years. Take a look at the 5 year chart.
Trading at 2 times second half of year annualized earnings. With morgan stanely asia having 2 people on the board and their 100 million dollar investment any hint of fraud completely out the window. Of course with no catalyst until q3 earnings in November I assume the current horizontal trading will continue despite the valuation.
I generally invest in Biotech or wherever I see value and insider buying. I'm not an accountant but their growth, net income and eps all seem great....why the low price, why under the radar? I know I'm not smarter then the market and the majority of full time investors, so any thoughts?